Galena Biopharma Inc (NASDAQ:GALE) Appoints Stephen F. Ghiglieri In A Bid To Foster Development

Galena Biopharma Inc (NASDAQ:GALE) has seen it fit to appoint Stephen F. Ghiglieri in the position of the interim chief executive officer. The company has done that through its board of directors which of course believes the change will help take development to new heights. At the same time, the board has insisted that Stephen.F. Ghiglieri also gets to retain his earlier position as the company’s chief financial officer.

The Chairman of Galena’s Board of Directors, Sanford J. Hillsberg, spoke on behalf of the board of directors and in making his statement showed how happy they were with their new move. To reach their decision, the official revealed that they checked out the Ghiglieri’s public company experience. The board of directors looks forward to evaluating number strategic alternatives that will help steer the company towards high levels of success especially in terms of giving a boost to stockholder value. A rise in the NASDAQ Stock standing would be welcomed with joy.

In making his statement, Mr. Ghiglieri said, “Over the course of my career, I have been involved with various companies that have gone through transitions and believe that my experience will be beneficial to all of our stakeholders as we seek an optimal outcome for Galena. I look forward to working with our Board of Directors and management team to ensure the company continues to execute as we identify opportunities to enhance our value,”

November 2016 is the year the newly appointed official got the chance to work with Galena Biophama. He boasts of a high level of experience considering that he spent about 25 years in the senior level finance and at this point in time he carried out operational roles at both the technology companies and biotechnological ones. Before joining Galena, Mr. Ghiglieri had been serving in the capacity of the CFO of MedData Inc.Mednax took up this company after paying the required price. At NeurogesX, the official spend 10 years and by the time he was moving out, he had already clinched the position of the company’s Executive Vice president, CFO and operating officer.

The other place he served was Hansen Medical, Inc. In this company, he offered services as the CFO. Hansen Medical Inc happens to be one of the renowned medical device companies. The new appointment inspires great hope in the company and who knows? May be the NASDAQ Stock standing will change.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 All RIGHTS RESERVED.